165 related articles for article (PubMed ID: 34306255)
1. GABPA Expression in Endometrial Carcinoma: A Prognostic Marker.
Ma X; Lin Q; Cui G; Zhao J; Wei X; Li R; Mao H; Ma Y; Liu P; Pang Y
Dis Markers; 2021; 2021():5552614. PubMed ID: 34306255
[TBL] [Abstract][Full Text] [Related]
2. GABPA predicts prognosis and inhibits metastasis of hepatocellular carcinoma.
Zhang S; Zhang K; Ji P; Zheng X; Jin J; Feng M; Liu P
BMC Cancer; 2017 May; 17(1):380. PubMed ID: 28549418
[TBL] [Abstract][Full Text] [Related]
3. RRBP1 overexpression is associated with progression and prognosis in endometrial endometrioid adenocarcinoma.
Liu S; Lin M; Ji H; Ding J; Zhu J; Ma R; Meng F
Diagn Pathol; 2019 Jan; 14(1):7. PubMed ID: 30684972
[TBL] [Abstract][Full Text] [Related]
4. Expression of bone morphogenetic protein 10 in cases with endometrial carcinoma and its clinical significance.
Hu Y; Yu L; Xia F; Liang F; Cheng C; Huang Y; Xiao L
Clin Transl Oncol; 2021 Aug; 23(8):1711-1716. PubMed ID: 33635467
[TBL] [Abstract][Full Text] [Related]
5. Rictor is an independent prognostic factor for endometrial carcinoma.
Wen SY; Li CH; Zhang YL; Bian YH; Ma L; Ge QL; Teng YC; Zhang ZG
Int J Clin Exp Pathol; 2014; 7(5):2068-78. PubMed ID: 24966915
[TBL] [Abstract][Full Text] [Related]
6. [High expression of MMP20 may be a potential prognostic factor for poor outcomes of patients with endometrial carcinoma].
Zhao Q; Liu S
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1239-1244. PubMed ID: 30377136
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Nucleolin is a Potential Prognostic Marker in Endometrial Carcinoma.
Lin Q; Ma X; Hu S; Li R; Wei X; Han B; Ma Y; Liu P; Pang Y
Cancer Manag Res; 2021; 13():1955-1965. PubMed ID: 33658856
[TBL] [Abstract][Full Text] [Related]
8. High nuclear expression of HDGF correlates with disease progression and poor prognosis in human endometrial carcinoma.
Wang L; Jiang Q; Hua S; Zhao M; Wu Q; Fu Q; Fang W; Guo S
Dis Markers; 2014; 2014():298795. PubMed ID: 24692842
[TBL] [Abstract][Full Text] [Related]
9. Expression and clinical significance of retinoid X receptor α in esophageal carcinoma.
Ren HY; Guo YH; Yang LM; Dai TJ; Lin MZ; Yu L; Zhu QG; Meng JR
Ann Diagn Pathol; 2018 Jun; 34():110-115. PubMed ID: 29661715
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value and Immune-Infiltration Pattern of
Yang Z; Shen X; Luo S; Li Y
Dis Markers; 2022; 2022():9621701. PubMed ID: 35126794
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients.
Bignotti E; Ragnoli M; Zanotti L; Calza S; Falchetti M; Lonardi S; Bergamelli S; Bandiera E; Tassi RA; Romani C; Todeschini P; Odicino FE; Facchetti F; Pecorelli S; Ravaggi A
Br J Cancer; 2011 Apr; 104(9):1418-25. PubMed ID: 21468050
[TBL] [Abstract][Full Text] [Related]
12. WNT5A gene and protein expression in endometrial cancer.
Wasniewski T; Kiezun J; Krazinski BE; Kowalczyk AE; Szostak B; Wierzbicki PM; Kiewisz J
Folia Histochem Cytobiol; 2019; 57(2):84-93. PubMed ID: 31198984
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of HPIP as a biomarker for metastasis and prognosis prediction in endometrial cancer patients.
Cheng L; Zhao T; Li S; Wang Y; Fei H; Meng F
J Clin Lab Anal; 2019 Oct; 33(8):e22959. PubMed ID: 31241209
[TBL] [Abstract][Full Text] [Related]
14. Silencing of UCA1, a poor prognostic factor, inhibited the migration of endometrial cancer cell.
Lu L; Shen Y; Tseng KF; Liu W; Duan H; Meng W
Cancer Biomark; 2016 Jun; 17(2):171-7. PubMed ID: 27540975
[TBL] [Abstract][Full Text] [Related]
15. Alternative splicing-related factor YT521: an independent prognostic factor in endometrial cancer.
Zhang B; zur Hausen A; Orlowska-Volk M; Jäger M; Bettendorf H; Stamm S; Hirschfeld M; Yiqin O; Tong X; Gitsch G; Stickeler E
Int J Gynecol Cancer; 2010 May; 20(4):492-9. PubMed ID: 20686370
[TBL] [Abstract][Full Text] [Related]
16. Stathmin is a marker of progression and poor prognosis in esophageal carcinoma.
Wang F; Xuan XY; Yang X; Cao L; Pang LN; Zhou R; Fan QX; Wang LX
Asian Pac J Cancer Prev; 2014; 15(8):3613-8. PubMed ID: 24870766
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of ANCCA/ATAD2 in endometrial carcinoma and its correlation with tumor progression and poor prognosis.
Shang P; Meng F; Liu Y; Chen X
Tumour Biol; 2015 Jun; 36(6):4479-85. PubMed ID: 25934333
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of PKN1 as a Prognosis Biomarker for Endometrial Cancer.
Govorov I; Attarha S; Kovalevska L; Andersson E; Kashuba E; Mints M
Cancer Control; 2022; 29():10732748221094797. PubMed ID: 35533253
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of Sam68 expression in endometrial carcinoma.
Wang Q; Li Y; Zhou J; Liu J; Qin J; Xing F; Zhang J; Cheng J
Tumour Biol; 2015 Jun; 36(6):4509-18. PubMed ID: 25874492
[TBL] [Abstract][Full Text] [Related]
20. miR-944 acts as a prognostic marker and promotes the tumor progression in endometrial cancer.
He Z; Xu H; Meng Y; Kuang Y
Biomed Pharmacother; 2017 Apr; 88():902-910. PubMed ID: 28178620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]